TTM-002

N/A

Report date: 2025/07/16 17:08:37
NME

Base Information

Drug NameTTM-002
Drug Alias NameTTM-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel alpha2/delta subunit 1 modulators
TargetsVoltage-gated calcium channel alpha2/delta subunit 1
Therapy Area/IndicationsTauopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKyoto University
China Registration ClassN/A

Develop Information

Active CompaniesTime Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsTauopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A